Three popular over-the-counter pain medications have been recalled by Glenmark Pharmaceuticals Inc. USA due to manufacturing issues, according to the Food and Drug Administration.
The recalled products are generic versions of Aleve (naproxen sodium), Tylenol (acetaminophen), and Advil (ibuprofen).
According to an FDA report, published on April 8, the recall was initiated because of current good manufacturing practice regulation deviations.
Products with this issue could include problems like incorrect dosages of active ingredients or exposure to elements like humidity during transport. The exact quality control issues were not immediately clear.
The following products were recalled:
- 100-count naproxen sodium tablets that were packaged in bottles with the lot number 17231956 and had an August 2025 expiration date.
- 144 and 216-count acetaminophen and ibuprofen combination tablets that were packaged in bottles with the lot numbers 17241302, 17241140, and 17241141, all with July 2026 expiration dates.
These combination tablets may have been sold at Amazon and Walmart, but this is not confirmed, according to the administration.
The administration has classified this as a Class II recall, which is when exposure to the product “may cause temporary or medically reversible adverse health effects.”
It is unknown exactly how much medication was affected by this recall.
Consumers should properly dispose of the pills, the administration advised.